Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.89% | -87.26% | 60.48% | 14,256.25% | 2,175.41% |
| Total Receivables | -42.13% | 152.78% | 157.80% | 206.83% | 217.68% |
| Inventory | 42.69% | 117.71% | -26.21% | 1,344.16% | 710.53% |
| Prepaid Expenses | -69.26% | -64.52% | 102.58% | -42.42% | -22.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -0.85% | -49.93% | 66.76% | 853.17% | 266.20% |
|
|
|||||
| Total Current Assets | -0.85% | -49.93% | 66.76% | 853.17% | 266.20% |
| Net Property, Plant & Equipment | 11.61% | 17.62% | 12.39% | 7.76% | 6.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 6.19% | 0.00% | -1.92% | -0.97% |
| Total Assets | 8.82% | -1.17% | 19.84% | 54.76% | 25.84% |
|
|
|||||
| Total Accounts Payable | 186.15% | -15.87% | -9.29% | 21.12% | 26.70% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -70.94% | 203.01% | -15.03% | 83.98% | 129.02% |
| Total Other Current Liabilities | -70.94% | 203.01% | -15.03% | 83.98% | 129.02% |
| Total Current Liabilities | 41.37% | 26.30% | -13.20% | 60.41% | 92.05% |
|
|
|||||
| Total Current Liabilities | 41.37% | 26.30% | -13.20% | 60.41% | 92.05% |
| Long-Term Debt | -- | -- | 0.00% | -1.69% | -0.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -1.92% | -0.97% |
| Total Liabilities | 37.63% | 22.83% | -13.52% | 57.99% | 87.41% |
|
|
|||||
| Common Stock & APIC | 24.86% | 29.24% | 38.88% | 29.76% | 15.40% |
| Retained Earnings | -30.84% | -36.18% | -32.98% | -27.81% | -20.74% |
| Treasury Stock & Other | -1.65% | -54.55% | 0.67% | -34.09% | 23.47% |
| Total Common Equity | -55.42% | -41.07% | 179.11% | 50.01% | -27.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -55.42% | -41.07% | 179.11% | 50.01% | -27.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -55.42% | -41.07% | 179.11% | 50.01% | -27.36% |
|
|
|||||